TETRA Technologies Inc Oil & Gas Exploration and Production Operations and Cost Analysis – 2017

◆英語タイトル:TETRA Technologies Inc Oil & Gas Exploration and Production Operations and Cost Analysis - 2017
◆商品コード:DATA904C3268
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:42
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:グローバル
◆産業分野:石油・ガス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

TETRA Technologies Inc Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
Summary

TETRA Technologies Inc (TETRA) is an oil and gas company that offers completion fluids and associated products and services. The company’s services comprise compression services, fluid, filtration and tools services, offshore services, production testing, rig cooling services, technology center and water management solutions. Its production testing services offers exploration and appraisal, development, production, surface well testing, cleanup services, blowout preventer services, laboratory services, railroad commission testing, safety and training, and equipment. The company also offers offshore services such as well plugging and abandonment, decommissioning, and diving. It serves its clients in the US and abroad. TETRA is headquartered in Houston, Texas, the US.

TETRA Technologies Inc Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key operational metrics, analysis and provides a strategic insight into the company. The report provides an annual and quarterly overview of oil and gas reserves and production, changes in reserves, costs incurred and results of oil and gas operations, acreage and well details, share price performance and key valuation metrics.

Scope

The report provides in-depth analysis and insights into companies’ capital spending, revenues, oil and gas reserves, production, and performance measures. Its scope includes the following –
- The report provides detailed and unique insight information on the key operational metrics. It gives a comprehensive overview of oil and gas production and reserves, costs incurred and results of oil and gas operations, acreage and well details and other performance metrics.
- Provides details with respect to the company’s oil and gas reserves and production information by country. It further consists of in-depth information on the company’s expenditures in relation to the acquisition, exploration and development activities; developed and undeveloped acreage position; key costs and revenue information; and performance metrics of the company as disclosed in its annual reports and regulatory filings.
- Provides a comprehensive overview of the company’s share price performance and key valuation metrics such as market capitalization, enterprise value, EV/Production ($boe/d) and EV/Proved Reserve ($/boe)
- Provides information on key operational and financial metrics on an annual and quarterly basis. The annual information provided is for a five-year period and the quarterly information is for the last five quarters.

*Note:

1. The scope mentioned above is generic and may not apply to all the companies. The report is based on the information disclosed by the companies in their annual and quarterly reports, regulatory filings and other company documents and sources.
2. Quarterly information is provided only for the companies that are December ending and files quarter reports and documents.
3. There can be cases where countries/regions data column/Charts will be blank. This can be due to the fact that the company might have discontinued the reporting of those countries/regions. Information that is not disclosed by the company may not be available in the report.

Reasons to buy

The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to –
- Be up-to-date with the latest information and in-depth analysis of the operational metrics of the company.
- Identify M&A targets from up-to-date information and in-depth analysis on financial and operational metrics of your competitors.
- Rank your performance against other companies in the exploration and production (E&P) sector using operational and financial benchmarking metrics.
- Formulate your strategies based on in-depth analysis of your competitors’ financial and operational data.
- Exploit the strengths and weakness of your closest competitors by comparing and analyzing their financial and operational metrics.
- Establish relative performance among the industry’s players based on key operational and financial measures.

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Company Snapshot 4
Key Information 4
Company Overview 4
TETRA Technologies Inc, Valuation and Financial Data, 2013-2017 5
TETRA Technologies Inc, Share Price Performance, 2013-2017 5
Share Price Performance, 2013-2017 5
TETRA Technologies Inc, Production and Reserves Trends 7
Oil and Gas Cost Per boe, US$/boe 7
TETRA Technologies Inc, Reserve Replacement Ratio 8
Oil and Gas Production Replacement Ratio 8
Oil and Gas Production Replacement Ratio, 2013-2017 8
TETRA Technologies Inc, Results of Oil & Gas Operations Trend 11
Oil and Gas Revenue and Expenses 11
Oil and Gas Revenue and Expenses, 2013-2017 11
TETRA Technologies Inc, Land Holdings and Well Data 16
Developed and Undeveloped Acreage 16
Gross and Net Developed and Undeveloped Acreage, 2013-2017 16
Well Statistics 18
Producible Oil and Gas Well, 2013-2017 18
Recent Developments 20
TETRA Technologies Inc – Recent Developments 20
Aug 09, 2018: TETRA Technologies Announces Second Quarter Results And Provides Update To Total Year Guidance 20
Aug 09, 2018: TETRA Technologies Announces Second Quarter Results And Provides Update To Total Year Guidance 22
Aug 09, 2018: TETRA Technologies Announces Second Quarter Results And Provides Update To Total Year Guidance 25
Jul 18, 2018: TETRA technologies announces appointment of Gina A. Luna as director 27
Jul 02, 2018: TETRA Technologies And Halliburton Sign Global Marketing And Development Agreement For TETRA CS Neptune Completion Fluids 28
May 08, 2018: TETRA Technologies Announces First Quarter Results And Provides Total Year Guidance 28
Mar 01, 2018: Tetra Technologies agrees to divest offshore decommissioning services 31
Feb 28, 2018: TETRA Technologies Announces Fourth Quarter And Full Year 2017 Results 32
Nov 09, 2017: TETRA Technologies Announces Third Quarter 2017 Results And Provides Updated Total Year 2017 Guidance 34
Aug 09, 2017: TETRA Technologies Announces Second Quarter 2017 Results 36
Appendix 39
Methodology 39
Coverage 39
Secondary Research 39
Primary Research 40
Data Information Sources 40
Company Source 40
SEC/Other Regulatory Filings 40
Other Sources 40
Expert Panel Validation 40
Data Definition 40
Oil and Gas Reserves 40
Units of Measure 41
About GlobalData 42
Disclosure 42
Disclaimer 42

List of Tables
Table 1: TETRA Technologies Inc, Key Facts 4
Table 2: TETRA Technologies Inc, Share Price Performance, 2013-2017 5
Table 3: TETRA Technologies Inc, Key Valuation Metrics, 2013-2017 6
Table 4: TETRA Technologies Inc, Reserves Replacement, Finding and Development Costs, Finding Cost and Proved Acquisition Costs Per boe, US$/boe, 2013-2017 7
Table 5: TETRA Technologies Inc, Oil and Gas Production Replacement Ratio, %, 2013-2017 9
Table 6: TETRA Technologies Inc, 3-Year Wt.Avg. Oil and Gas Production Replacement Ratio, By Country/Region, %, 2013-2017 10
Table 7: TETRA Technologies Inc, Revenue and Expenses, US$ mil, 2013-2017 12
Table 8: TETRA Technologies Inc, Revenue and Expenses, By Country/Region, US$ mil, 2013-2017 14
Table 9: TETRA Technologies Inc, Oil and Gas Performance Metrics, 2013-2017 15
Table 10: TETRA Technologies Inc, Land Holdings (Developed and Undeveloped Acreage), Acres, 2013-2017 16
Table 11: TETRA Technologies Inc, Land Holdings (Developed and Undeveloped Acreage), By Country/Region, Acres, 2013-2017 17
Table 12: TETRA Technologies Inc, Producible Oil and Gas Wells, 2013-2017 18
Table 13: TETRA Technologies Inc, Producible Oil and Gas Wells, By Country/Region, 2013-2017 19

List of Figures
Figure 1: TETRA Technologies Inc, Share Price Performance, USD/Share, 2013-2017 5
Figure 2: TETRA Technologies Inc, 3-Year Wt.Avg., Oil and Gas Production Replacement Ratio, %, 2013-2017 8
Figure 3: TETRA Technologies Inc, Revenue and Expenses, US$ mil, 2013-2017 11
Figure 4: TETRA Technologies Inc, Oil & Gas Revenue, By Country/Region, US$ mil, 2013-2017 13
Figure 5: TETRA Technologies Inc, Total Expenses From Upstream Oil & Gas Operations, By Country/Region, US$ mil, 2013-2017 13
Figure 6: TETRA Technologies Inc, Oil and Gas Performance Metrics, 2013-2017 15
Figure 7: TETRA Technologies Inc, Land Holdings (Developed and Undeveloped Acreage), Acres, 2013-2017 16
Figure 8: TETRA Technologies Inc, Producible Oil and Gas Wells, 2013-2017 18

★海外企業調査レポート[TETRA Technologies Inc Oil & Gas Exploration and Production Operations and Cost Analysis – 2017]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Solo Oil plc (SOLO):企業の財務・戦略的SWOT分析
    Summary Solo Oil Plc (Solo Oil), formerly Immersion Technologies International Plc, is an oil and gas exploration and production company that acquires, explores, develops and produces oil and gas resource development and production assets. The company's non operated oil and gas assets portfolio incl …
  • Kallpa Generacion SA:企業の発電所・SWOT分析2018
    Kallpa Generacion SA - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employee …
  • AnaBios Corp-製薬・医療分野:企業M&A・提携分析
    Summary AnaBios Corp (AnaBios) is a pre-clinical stage contract research organization which carries out drug efficacy studies on human samples. Its products portfolio includes human dorsal root ganglia (hDRG) neuron cultures, human heart tissue samples,human cardiac mesenchymal stem cells, human bra …
  • ERI Bancaire SA:企業の戦略的SWOT分析
    ERI Bancaire SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Pierrel Spa (PRL)-製薬・医療分野:企業M&A・提携分析
    Summary Pierrel Spa (Pierrel) is a pharmaceutical company that offers contract services to biopharmaceutical and life sciences industries across the world. The company offers services in the areas of contract research, discovery of medicinal product candidates, clinical research and contract manufac …
  • Teijin Limited:企業の戦略・SWOT・財務分析
    Teijin Limited - Strategy, SWOT and Corporate Finance Report Summary Teijin Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Amathus Public Ltd:企業の戦略・SWOT・財務情報
    Amathus Public Ltd - Strategy, SWOT and Corporate Finance Report Summary Amathus Public Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Shinva Medical Instrument Co Ltd (600587)-医療機器分野:企業M&A・提携分析
    Summary Shinva Medical Instrument Co., Ltd. (Shinva Medical) manufactures and markets medical instruments and environmental protection equipment for various healthcare markets. The company’s products portfolio includes sterilizers, radiotherapy equipment, digital diagnosis equipment, surgical instru …
  • DS Smith Plc:企業のM&A・事業提携・投資動向
    DS Smith Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's DS Smith Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Komunalna poistovna, a.s. Vienna Insurance Group:企業の戦略的SWOT分析
    Komunalna poistovna, a.s. Vienna Insurance Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competit …
  • Sotera Health LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Sotera Health LLC (Sotera Health), formerly Sterigenics International LLC, a subsidiary of GTCR LLC, is a medical device company. The company offers sterilization technologies such as gamma irradiation, electron beam and ethylene oxide. Its services include drug device combination, vaccine s …
  • BP Plc Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    BP Plc Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary BP Plc (BP) is an integrated oil and gas company. Its upstream activities include exploration, development and production of oil and natural gas, field development and production; and midstream operations inc …
  • Alnylam Pharmaceuticals Inc (ALNY):医療機器:M&Aディール及び事業提携情報
    Summary Alnylam Pharmaceuticals Inc (Alnylam) is a biopharmaceutical company which discovers, develops and commercializes therapeutics based on Ribo Nucleic Acid interference (RNAi). The company offers a broad pipeline of investigational RNAi therapeutics in the areas of genetic medicines, hepatic i …
  • CNOOC Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – Q3, 2017
    CNOOC Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2017 Summary CNOOC Ltd (CNOOC) is an upstream oil and gas company. It carries out exploration, development, production and sale of crude oil and natural gas. The company has operations in Bohai, Western South China Sea …
  • Hong Leong Asia Ltd (H22):企業の財務・戦略的SWOT分析
    Hong Leong Asia Ltd (H22) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Anworth Mortgage Asset Corp (ANH):企業の財務・戦略的SWOT分析
    Summary Anworth Mortgage Asset Corp (Anworth) is a financial service provider that provides mortgage real estate investment services. The company invests in mortgage-backed securities on a leveraged basis. It operates through agency credit-backed securities and non-agency credit-backed securities. A …
  • Blueprint Medicines Corp (BPMC):製薬・医療:M&Aディール及び事業提携情報
    Summary Blueprint Medicines Corp (Blueprint Medicines), formerly Hoyle Pharmaceuticals Inc, is a drug discovery company that develops drugs for the treatment of cancers and rare diseases. The company discovers and develops selective kinase inhibitors for genomically defined cancer subsets. Its pipel …
  • BioDelivery Sciences International Inc (BDSI)-製薬・医療分野:企業M&A・提携分析
    Summary BioDelivery Sciences International Inc (BDSI) is a specialty pharmaceutical company which develops and commercializes products in the areas of addiction medicine and pain management. The company’s marketed products include fentanyl buccal soluble solution for breakthrough cancer pain; bupren …
  • Antibe Therapeutics Inc (ATE):企業の財務・戦略的SWOT分析
    Summary Antibe Therapeutics Inc (Antibe) is a biotech company that designs and develops drug candidates for chronic pain and inflammation; and regenerative medicine. The company discovers and commercializes novel drugs, biologics and medical devices. It offers lead compound ATB-346, a naproxen deriv …
  • Rich Pharmaceuticals Inc (RCHA):製薬・医療:M&Aディール及び事業提携情報
    Summary Rich Pharmaceuticals Inc (Rich Pharmaceuticals) is a biopharmaceutical company that offers discovery and development of therapies for the treatment of acute myelogenous leukemia (AML) in refractory patients. The company’s pipeline portfolio offers a lead drug candidate for the treatment of a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆